Literature DB >> 31697173

Validity of Veterans Health Administration structured data to determine accurate smoking status.

Sara E Golden, Elizabeth R Hooker, Sarah Shull, Matthew Howard1, Kristina Crothers2, Reid F Thompson3, Christopher G Slatore4.   

Abstract

We compared smoking status from Veterans Health Administration (VHA) structured data with text in electronic health record (EHR) to assess validity. We manually abstracted the smoking status of 5,610 VHA patients. Only those with a smoking status found in both EHR text data and VHA structured data were included (n=5,289). We calculated agreement and kappa statistics to compare structured data vs. manually abstracted EHR text smoking status. We found a kappa statistic of 0.70 and total agreement of 81.1% between EHR text data and structured data for Current, Former, and Never smoking categories. Comparing EHR text data and structured data between Never and Ever smokers revealed a kappa statistic of 0.62 and total agreement of 89.1%. For comparison between Current and Never/Former smokers, the kappa statistic was 0.80 and total agreement was 90.2%. We found substantial and significant agreement between smoking status in EHR text data and structured data that may aid in future research.

Entities:  

Keywords:  informatics; public health; smoking/harm reduction

Mesh:

Year:  2019        PMID: 31697173     DOI: 10.1177/1460458219882259

Source DB:  PubMed          Journal:  Health Informatics J        ISSN: 1460-4582            Impact factor:   2.681


  8 in total

1.  Cause-Specific Mortality in Patients with Gout in the United States Veteran's Health Administration: A Matched Cohort Study.

Authors:  Lindsay N Helget; Bryant R England; Punyasha Roul; Harlan Sayles; Alison D Petro; Tuhina Neogi; James R O'Dell; Ted R Mikuls
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-16       Impact factor: 5.178

2.  The Impact of Persistent Smoking After Surgery on Long-term Outcomes After Stage I Non-small Cell Lung Cancer Resection.

Authors:  Brendan T Heiden; Daniel B Eaton; Su-Hsin Chang; Yan Yan; Martin W Schoen; Li-Shiun Chen; Nina Smock; Mayank R Patel; Daniel Kreisel; Ruben G Nava; Bryan F Meyers; Benjamin D Kozower; Varun Puri
Journal:  Chest       Date:  2021-12-14       Impact factor: 10.262

3.  Onset of Skin, Gut, and Genitourinary Prodromal Parkinson's Disease: A Study of 1.5 Million Veterans.

Authors:  Gregory D Scott; Miranda M Lim; Matthew G Drake; Randy Woltjer; Joseph F Quinn
Journal:  Mov Disord       Date:  2021-05-03       Impact factor: 10.338

4.  National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System.

Authors:  Jose P Zevallos; Jennifer R Kramer; Vlad C Sandulache; Sean T Massa; Christine M Hartman; Angela L Mazul; Benjamin M Wahle; Sophie P Gerndt; Erich M Sturgis; Elizabeth Y Chiao
Journal:  Head Neck       Date:  2020-09-12       Impact factor: 3.821

5.  Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer.

Authors:  Kamya Sankar; Alex K Bryant; Garth W Strohbehn; Lili Zhao; David Elliott; Drew Moghanaki; Michael J Kelley; Nithya Ramnath; Michael D Green
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

6.  Assessing Smoking Status and Risk of SARS-CoV-2 Infection: A Machine Learning Approach among Veterans.

Authors:  Alice B S Nono Djotsa; Drew A Helmer; Catherine Park; Kristine E Lynch; Amir Sharafkhaneh; Aanand D Naik; Javad Razjouyan; Christopher I Amos
Journal:  Healthcare (Basel)       Date:  2022-07-04

7.  Thromboembolic risk in patients with lung cancer receiving systemic therapy.

Authors:  Cecelia J Madison; Ryan A Melson; Michael J Conlin; Kenneth R Gundle; Reid F Thompson; David C Calverley
Journal:  Br J Haematol       Date:  2021-06-16       Impact factor: 8.615

8.  Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans.

Authors:  Javad Razjouyan; Drew A Helmer; Kristine E Lynch; Nicola A Hanania; Paul E Klotman; Amir Sharafkhaneh; Christopher I Amos
Journal:  Nicotine Tob Res       Date:  2022-03-26       Impact factor: 4.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.